Louisiana State Employees Retirement System purchased a new stake in Integer Holdings Corporation (NYSE:ITGR – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 15,500 shares of the medical equipment provider’s stock, valued at approximately $1,364,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Salomon & Ludwin LLC increased its holdings in Integer by 46.8% in the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 118 shares during the period. TD Private Client Wealth LLC boosted its position in shares of Integer by 1,037.5% during the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 415 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in shares of Integer by 135.5% during the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock worth $36,000 after acquiring an additional 267 shares in the last quarter. Arax Advisory Partners increased its stake in Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 473 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in Integer by 193.2% in the fourth quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock valued at $41,000 after acquiring an additional 342 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.
Analysts Set New Price Targets
ITGR has been the subject of several recent analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Integer in a research note on Thursday, June 18th. Piper Sandler reiterated an “overweight” rating and issued a $97.00 price target (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Citigroup boosted their price target on Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a report on Thursday, May 28th. Finally, Zacks Research downgraded Integer from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $98.71.
Integer Price Performance
ITGR stock opened at $95.18 on Friday. The company has a fifty day moving average price of $89.72 and a 200-day moving average price of $86.25. The company has a market capitalization of $3.23 billion, a P/E ratio of 23.74, a PEG ratio of 2.25 and a beta of 0.64. Integer Holdings Corporation has a 52-week low of $62.00 and a 52-week high of $122.99. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75.
Integer (NYSE:ITGR – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). The business had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities analysts expect that Integer Holdings Corporation will post 6.04 EPS for the current year.
Integer Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Featured Articles
- Five stocks we like better than Integer
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
